# Traws Pharma is responding to the threat of Hantavirus, a rodent-borne negative-strand RNA virus.

*biotech · news · 2026-05-08 · The Manila Times*

## Key points

- Traws Pharma is advancing clinical candidates specifically for the treatment of hantavirus infections.
- Recent cruise ship fatalities and illnesses have been linked to a hantavirus outbreak.
- Traws' antiviral candidates have previously demonstrated inhibition of negative-strand virus replication.
- No approved treatments exist for Hantaan pulmonary disease, highlighting the urgent need for new therapies.

**Companies:** Traws Pharma
**Countries:** United States

[Read the full story on The Manila Times](https://www.manilatimes.net/2026/05/08/tmt-newswire/globenewswire/traws-pharma-to-advance-potential-clinical-candidates-for-the-treatment-of-hantavirus-infections/2339421)

---

Canonical: https://newsio.io/n/ad91ca1d-b7cf-4fbd-b6bb-404e6d740bd3/traws-pharma-is-responding-to-the-threat-of-hantavirus-a-rodent-borne-negative-s
Summarized by Newsio from The Manila Times. https://newsio.io/how-it-works